EFFECTS OF CALCITONIN THERAPY ON OSTEOPOROSIS IN PATIENTS WITH THALASSEMIA

CANATAN D., AKAR N., ARCASOY A.

ACTA HAEMATOLOGICA, cilt.93, sa.1, ss.20-24, 1995 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 93 Sayı: 1
  • Basım Tarihi: 1995
  • Doi Numarası: 10.1159/000204084
  • Dergi Adı: ACTA HAEMATOLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.20-24
  • Anahtar Kelimeler: THALASSEMIA, OSTEOPOROSIS, CALCITONIN, CHILDREN
  • Ankara Üniversitesi Adresli: Hayır

Özet

The aim of this study was to evaluate the effects of calcitonin (CT) treatment on bone pain, osteoporosis, bone fractures and blood chemistry in thalassemic patients. Twenty-four patients with an age range of 10-24 years were included, 14 of whom received 100 IU CT and 250 mg calcium 3 times a week. The others (n = 10) were followed up as a control group with only routine thalassemia therapy. After 1 year of treatment, bone pain disappeared and radiological signs of osteoporosis had improved significantly (p < 0.01) in the treatment group. CT has no important side effects.